Continuous Intravenous Sodium Ferric Gluconate Improves Efficacy in the Maintenance Phase of EPOrHu Administration in Hemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9670|22|1|67-72

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.22, Iss.1, 2002-03, pp. : 67-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin

By  

Nephron, Vol. 80, Iss. 3, 1998-11 ,pp. : 369-370

Karger

Access to resources Recommend Favorite

Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin: 1-Year Follow-Up Study

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 200-201

Karger

Access to resources Recommend Favorite

Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency

By  

Nephron, Vol. 131, Iss. 3, 2015-0 ,pp. : 161-166

Karger

Access to resources Recommend Favorite

Ultrapure Dialysis Fluid Lowers the Cardiovascular Morbidity in Patients on Maintenance Hemodialysis by Reducing Continuous Microinflammation

By  

Nephron, Vol. 91, Iss. 3, 2002-07 ,pp. : 452-455

Karger

Access to resources Recommend Favorite

Vascular Calcification in Maintenance Hemodialysis Patients

By  

Blood Purification, Vol. 28, Iss. 1, 2009-03 ,pp. : 15-20

Karger

Access to resources Recommend Favorite